Correlative studies of a phase I trial of combination anti-vascular endothelial growth factor (VEGF) therapy with sorafenib and bevacizumab
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: N. S. Azad, L. Jain, C. Annunziata, L. Cao, L. Greenberg, L. Minasian, A. Perroy, H. Kotz, W. D. Figg, E. Kohn
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2591567047
